F13B and stroke disorder: Misra et al. used SWATH-MS-based proteomics to identify ceruloplasmin, α-1-antitrypsin (SERPINA1), von Willebrand factor (vWF), and coagulation factor XIII B chain (F13B) as effective biomarkers for distinguishing total stroke, ischemic stroke, and intracerebral hemorrhage (ICH) from healthy controls (20).